A nurse is monitoring a client who received epinephrine for angioedema after a first dose of losartan. Which of the following data indicates a therapeutic response to the epinephrine?

A) Painful urination: Painful urination, also known as dysuria, is not a typical symptom of BPH. Dysuria is more commonly associated with conditions such as urinary tract infections (UTIs) or urethritis rather than BPH.

B) Urge incontinence: While BPH can cause lower urinary tract symptoms such as urgency and frequency, urge incontinence (involuntary loss of urine associated with a sudden urge to urinate) is not typically a primary symptom of BPH. Urge incontinence is more commonly associated with overactive bladder (OAB) syndrome.

C) Critically elevated prostate-specific antigen (PSA) level: While BPH can cause an elevation in PSA levels, a critically elevated PSA level alone is not a definitive diagnostic finding for BPH. PSA levels can be elevated in various conditions affecting the prostate gland, including BPH, prostate cancer, and prostatitis. Therefore, PSA levels must be interpreted in conjunction with other clinical findings and diagnostic tests to accurately assess prostate health and diagnose specific prostate conditions.

D) Difficulty starting the flow of urine: Benign prostatic hyperplasia (BPH) is characterized by the enlargement of the prostate gland, which can obstruct the flow of urine through the urethra. This obstruction leads to symptoms such as difficulty starting the flow of urine, weak urinary stream, urinary hesitancy, and incomplete bladder emptying. These symptoms occur due to the mechanical obstruction of the urethra by the enlarged prostate gland. Difficulty starting the flow of urine is a hallmark symptom of BPH and is often one of the earliest manifestations experienced by affected individuals.

A) The client tolerates a second dose of medication with no greater than 1 peripheral edema:
This does not directly indicate a therapeutic response to epinephrine for angioedema. Angioedema primarily involves swelling of deeper layers of the skin, often around the eyes and lips, and sometimes the throat, which can cause breathing difficulties. Tolerating a second dose of medication with minimal peripheral edema does not specifically address the acute respiratory effects of angioedema.

B) Respirations are unlabored:
This is the correct answer. Angioedema can cause swelling in the airways, leading to difficulty breathing. Epinephrine is used to reduce this swelling and improve airway patency. Unlabored respirations indicate that the airway is not obstructed, which means the epinephrine has successfully alleviated the swelling causing the angioedema.

C) Client reports decreased groin pain of 3 on a 1 to 10 scale:
Decreased groin pain is not relevant to the treatment of angioedema with epinephrine. Pain relief in the groin area does not indicate a therapeutic response to epinephrine, which is primarily used to address airway and anaphylactic symptoms.

D) The client's blood pressure when arising from resting position is at premedication levels:
While epinephrine can affect blood pressure, the main concern with angioedema is airway obstruction rather than blood pressure control. Normalizing blood pressure does not specifically indicate that the epinephrine has successfully treated the angioedema and improved the client's respiratory status.